Reaction

Hypogonadism reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,005 reports · 36 co-occurring drugs

As of the last recalculation, Hypogonadism appears in 1,005 FAERS reports alongside 36 co-occurring drug terms. The strongest observed disproportionality signal is FINASTERIDE (PRR 154.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Finasteride311154.1154.9
Micafungin Sodium1742.242.3
Testosterone Cypionate1637.737.7
Testosterone3935.936.0
Brentuximab Vedotin1224.524.6
Bisacodyl Suppositories1524.424.4
Biscodyl1524.124.2
Ampicillin922.722.7
Ampicillin Sodium922.722.7
Bisacodyl1522.422.4
Pegaspargase1220.520.6
Thiamine Hydrochloride1220.220.2
Polyethylene Glycol1019.319.3
Posaconazole Delayed-Release1019.019.1
Sucralfate Oral1217.717.7
Dicyclomine Hydrochloride1217.617.7
Sucralfate Oral Suspension1217.617.6
Liothyronine Sodium614.314.4
Posaconazole1114.214.2
Ketoconazole Foam1014.114.2
Ketoconazole Cream, 2%1014.114.1
Meropenem2113.813.8
Bupivacaine613.413.4
Amphotericin B813.313.3
Filgrastim2312.912.9
Mesna Injection512.612.6
Voriconazole1812.512.5
Mesna512.412.4
Bicalutamide912.312.3
Ritonavir 100 Mg811.211.2
Amphetamine410.010.1
Ipilimumab209.89.8
Methadone Hydrochloride59.69.6
Ifosfamide98.78.7
Hydrocodone Bitartrate And Acetaminophen217.97.9
Alteplase56.96.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.